CBIO
Crescent Biopharma
CBIO
CBIO
69 hedge funds and large institutions have $338M invested in Crescent Biopharma in 2017 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.16% more ownership
Funds ownership: 0.82% → 0.98% (+0.16%)
70% less call options, than puts
Call options by funds: $337K | Put options by funds: $1.12M
Holders
69
Holding in Top 10
2
Calls
$337K
Puts
$1.12M
Top Buyers
| 1 | +$17.8M | |
| 2 | +$16.8M | |
| 3 | +$15.2M | |
| 4 |
Millennium Management
New York
|
+$14.9M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$9.59M |
Top Sellers
| 1 | -$5.08M | |
| 2 | -$1.56M | |
| 3 | -$1.25M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$869K |
| 5 |
Renaissance Technologies
New York
|
-$837K |